FDA Approved: TRODELVY — Original Application (Gilead Sciences, Inc.)

View source ↗

Summary

FDA approved TRODELVY (sacituzumab govitecan) under an original Biologics License Application for adults with metastatic triple-negative breast cancer who have …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Drugs mentioned

• TRODELVY (sacituzumab govitecan)

Snippet

ORIG AP for TRODELVY (SACITUZUMAB GOVITECAN)